Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01416142 · ClinicalTrials.gov registry record · NA

A Study to Evaluate the Product Performance of the PureVision®2 High Definition (HD) Contact Lens

A NA study of Myopia, sponsored by Bausch & Lomb Incorporated.

Completed
Registry status
NA
Development phase
63
Enrollment target
1
Study location

NCT01416142 is a NA study of Myopia that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 63 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01416142, a NA study of Myopia, has completed, sponsored by Bausch & Lomb Incorporated.

COMPLETED
Registry status
NA
Development phase
63 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to evaluate the product performance of PureVision2 HD contact lenses.

Conditions Studied

Myopia

Interventions

  • DEVICE Spectacles
  • DEVICE PureVision2 HD contact lenses

Study Locations (1)

New York

  • Bausch & Lomb, Inc. - Rochester

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2011-07
Est. Completion 2011-09
Phase NA

Sponsor

Bausch & Lomb Incorporated

174 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01416142

The ClinicalTrials.gov registry entry for NCT01416142 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (76% lower). The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Spectacles is the first listed.

NCT01416142 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01416142 about?

NCT01416142 is a clinical study titled "A Study to Evaluate the Product Performance of the PureVision®2 High Definition (HD) Contact Lens". The objective of this study is to evaluate the product performance of PureVision2 HD contact lenses.

What is the current status of trial NCT01416142?

This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2011-07. Estimated completion is 2011-09.

What conditions does trial NCT01416142 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT01416142?

The interventions under investigation include: Spectacles (DEVICE), PureVision2 HD contact lenses (DEVICE).

Who is sponsoring clinical trial NCT01416142?

This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01416142 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myopia

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.